Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9162294
[patent_doc_number] => 20130310571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'METHODS FOR THE PREPARATION OF BENDAMUSTINE'
[patent_app_type] => utility
[patent_app_number] => 13/981480
[patent_app_country] => US
[patent_app_date] => 2012-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4088
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981480
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/981480 | METHODS FOR THE PREPARATION OF BENDAMUSTINE | Jan 17, 2012 | Abandoned |
Array
(
[id] => 10063836
[patent_doc_number] => 09102667
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-11
[patent_title] => 'N-arylaminomethylene benzothiophenones for treatment of cardiovascular disease'
[patent_app_type] => utility
[patent_app_number] => 13/980057
[patent_app_country] => US
[patent_app_date] => 2012-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8007
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980057
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/980057 | N-arylaminomethylene benzothiophenones for treatment of cardiovascular disease | Jan 17, 2012 | Issued |
Array
(
[id] => 8173712
[patent_doc_number] => 20120108567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'Thiazolyl-Dihydro-Indazoles'
[patent_app_type] => utility
[patent_app_number] => 13/347797
[patent_app_country] => US
[patent_app_date] => 2012-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31408
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108567.pdf
[firstpage_image] =>[orig_patent_app_number] => 13347797
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/347797 | Thiazolyl-dihydro-indazoles | Jan 10, 2012 | Issued |
Array
(
[id] => 8301979
[patent_doc_number] => 20120184535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'COMPOUND, A PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND, A METHOD FOR MODULATING OR REGULATING SERINE/THREONINE KINASES AND A SERINE/THREONINE KINASES MODULATING AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/339104
[patent_app_country] => US
[patent_app_date] => 2011-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 31112
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339104
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/339104 | Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent | Dec 27, 2011 | Issued |
Array
(
[id] => 8909687
[patent_doc_number] => 08481751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-09
[patent_title] => 'Process for the production of bendamustine alkyl ester, bendamustine, and derivatives thereof'
[patent_app_type] => utility
[patent_app_number] => 13/334402
[patent_app_country] => US
[patent_app_date] => 2011-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6311
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13334402
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/334402 | Process for the production of bendamustine alkyl ester, bendamustine, and derivatives thereof | Dec 21, 2011 | Issued |
Array
(
[id] => 8749650
[patent_doc_number] => 08415483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-09
[patent_title] => 'Compounds and their use as BACE inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/331284
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 96896
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13331284
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/331284 | Compounds and their use as BACE inhibitors | Dec 19, 2011 | Issued |
Array
(
[id] => 10241739
[patent_doc_number] => 20150126734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'PROCESS FOR PREPARATION OF N,N-DI SUBSTITUTED CARBOXAMIDES'
[patent_app_type] => utility
[patent_app_number] => 14/356001
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5318
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14356001
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/356001 | PROCESS FOR PREPARATION OF N,N-DI SUBSTITUTED CARBOXAMIDES | Dec 19, 2011 | Abandoned |
Array
(
[id] => 9455483
[patent_doc_number] => 08716492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-06
[patent_title] => 'Five-membered heterocycles useful as serine protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/326809
[patent_app_country] => US
[patent_app_date] => 2011-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78995
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13326809
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/326809 | Five-membered heterocycles useful as serine protease inhibitors | Dec 14, 2011 | Issued |
Array
(
[id] => 10347450
[patent_doc_number] => 20150232455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'ANTI-VIRAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/368186
[patent_app_country] => US
[patent_app_date] => 2011-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21983
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14368186
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/368186 | ANTI-VIRAL COMPOUNDS | Dec 14, 2011 | Abandoned |
Array
(
[id] => 8240967
[patent_doc_number] => 20120149676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'NOVEL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/314561
[patent_app_country] => US
[patent_app_date] => 2011-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39464
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13314561
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/314561 | Compounds | Dec 7, 2011 | Issued |
Array
(
[id] => 8056231
[patent_doc_number] => 20120077853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/309452
[patent_app_country] => US
[patent_app_date] => 2011-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9868
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077853.pdf
[firstpage_image] =>[orig_patent_app_number] => 13309452
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/309452 | Human protein tyrosine phosphatase inhibitors and methods of use | Nov 30, 2011 | Issued |
Array
(
[id] => 8173739
[patent_doc_number] => 20120108576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'THIAZOLE COMPOUNDS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/307761
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34476
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108576.pdf
[firstpage_image] =>[orig_patent_app_number] => 13307761
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/307761 | THIAZOLE COMPOUNDS AND METHODS OF USE | Nov 29, 2011 | Abandoned |
Array
(
[id] => 8056485
[patent_doc_number] => 20120077984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'Process For Preparing Epothilone Derivatives By Selective Catalytic Epoxidation'
[patent_app_type] => utility
[patent_app_number] => 13/308046
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4330
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077984.pdf
[firstpage_image] =>[orig_patent_app_number] => 13308046
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/308046 | Process for preparing epothilone derivatives by selective catalytic epoxidation | Nov 29, 2011 | Issued |
Array
(
[id] => 8056511
[patent_doc_number] => 20120077985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'PROCESS FOR PRODUCING FUSED IMIDAZOLE COMPOUND, REFORMATSKY REAGENT IN STABLE FORM, AND PROCESS FOR PRODUCING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/305411
[patent_app_country] => US
[patent_app_date] => 2011-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 40187
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077985.pdf
[firstpage_image] =>[orig_patent_app_number] => 13305411
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/305411 | Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same | Nov 27, 2011 | Issued |
Array
(
[id] => 9149258
[patent_doc_number] => 20130303781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'PROCESS FOR PREPARATION OF TRICLABENDAZOLE'
[patent_app_type] => utility
[patent_app_number] => 13/989147
[patent_app_country] => US
[patent_app_date] => 2011-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1917
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989147
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/989147 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | Nov 22, 2011 | Abandoned |
Array
(
[id] => 9149259
[patent_doc_number] => 20130303782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'PROCESS FOR PREPARATION OF ALBENDAZOLE'
[patent_app_type] => utility
[patent_app_number] => 13/989497
[patent_app_country] => US
[patent_app_date] => 2011-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1558
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989497
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/989497 | PROCESS FOR PREPARATION OF ALBENDAZOLE | Nov 22, 2011 | Abandoned |
Array
(
[id] => 9149257
[patent_doc_number] => 20130303780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'PROCESS FOR THE PREPARATION OF 2-ARYLTHIAZOLE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/883843
[patent_app_country] => US
[patent_app_date] => 2011-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1700
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883843
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/883843 | PROCESS FOR THE PREPARATION OF 2-ARYLTHIAZOLE DERIVATIVES | Nov 2, 2011 | Abandoned |
Array
(
[id] => 9212078
[patent_doc_number] => 20140011255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'Biotin Derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/881518
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16729
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881518
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/881518 | Biotin derivatives | Oct 27, 2011 | Issued |
Array
(
[id] => 8173773
[patent_doc_number] => 20120108583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'Tricyclic Compounds As mPGES-1 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/283786
[patent_app_country] => US
[patent_app_date] => 2011-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71338
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108583.pdf
[firstpage_image] =>[orig_patent_app_number] => 13283786
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/283786 | Tricyclic compounds as mPGES-1 inhibitors | Oct 27, 2011 | Issued |
Array
(
[id] => 8095987
[patent_doc_number] => 20120083608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => 'PROCESS FOR THE PREPARATION OF [4-(2-CHLORO-4- METHOXY-5-METHYLPHENYL)-5-METHYL-THIAZOLO-2-YL]-[2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)-ETHYL]-AMINE'
[patent_app_type] => utility
[patent_app_number] => 13/282721
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1511
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20120083608.pdf
[firstpage_image] =>[orig_patent_app_number] => 13282721
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/282721 | Process for the preparation of [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl | Oct 26, 2011 | Issued |